Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Eur J Heart Fail. 2019 Apr;21(4):471-479. doi: 10.1002/ejhf.1389. Epub 2019 Jan 30.
To assess the association between atrial fibrillation (AF) and mortality, and also the association between resting heart rate (HR) and mortality in both sinus rhythm (SR) and AF in patients with heart failure with preserved ejection fraction (HFpEF).
A total of 9090 patients with HFpEF (ejection fraction ≥ 50%) were included from the Swedish Heart Failure registry; 4296 (47%) had SR and 4794 (53%) had AF. Patients with AF were older (80.3 vs. 75.0 years) and more symptomatic compared with patients in SR. The outcome measure was all-cause mortality. The adjusted hazard ratio (95% confidence interval) for AF vs. SR was 1.21 (1.11-1.32). Compared with HR ≤ 60 b.p.m., the adjusted hazard ratios (95% confidence interval) were in SR: 1.06 (0.92-1.21) for HR 61-70 b.p.m., 1.30 (1.12-1.52) for HR 71-80 b.p.m., 1.27 (1.07-1.51) for HR 81-90 b.p.m., and 1.77 (1.45-2.17) for HR > 90 b.p.m. Due to non-proportional hazards in AF, hazard ratios were estimated in three time periods. Compared with HR ≤ 60 b.p.m., the adjusted hazard ratios (95% confidence interval) were in AF: 1.30 (1.07-1.57), 1.07 (0.83-1.39), and 1.01 (0.70-1.48) for HR 61-70 b.p.m., 1.35 (1.12-1.62), 0.99 (0.77-1.27), and 0.96 (0.66-1.40) for HR 71-80 b.p.m., 1.41 (1.16-1.73), 1.01 (0.76-1.36), and 0.79 (0.51-1.22) for HR 81-90 b.p.m., and 1.78 (1.46-2.17), 1.08 (0.80-1.46), and 0.73 (0.46-1.17) for HR > 90 b.p.m., during 0-2, 2-4, and 4-6 years of follow-up, respectively.
In a large and unselected cohort of patients with HFpEF, AF was independently associated with all-cause mortality. A higher HR was associated with increased mortality in SR. In AF, the effect of a higher HR on mortality was only present during the first years of follow-up, with convergence in outcomes according to baseline HR groups over long-term follow-up.
评估在射血分数保留的心力衰竭(HFpEF)患者中,窦性心律(SR)和心房颤动(AF)患者的心房颤动(AF)与死亡率之间的关系,以及静息心率(HR)与死亡率之间的关系。
共纳入来自瑞典心力衰竭注册中心的 9090 例 HFpEF 患者(射血分数≥50%);4296 例(47%)有 SR,4794 例(53%)有 AF。与 SR 相比,AF 患者年龄更大(80.3 岁 vs. 75.0 岁),且症状更严重。主要结局为全因死亡率。与 SR 相比,AF 的调整后的危险比(95%置信区间)为 1.21(1.11-1.32)。与 HR≤60 b.p.m.相比,SR 中的调整后的危险比(95%置信区间)分别为 HR 61-70 b.p.m.为 1.06(0.92-1.21),HR 71-80 b.p.m.为 1.30(1.12-1.52),HR 81-90 b.p.m.为 1.27(1.07-1.51),HR>90 b.p.m.为 1.77(1.45-2.17)。由于 AF 中存在非比例风险,因此在三个时间段内估计了危险比。与 HR≤60 b.p.m.相比,AF 中的调整后的危险比(95%置信区间)分别为 HR 61-70 b.p.m.为 1.30(1.07-1.57),HR 71-80 b.p.m.为 1.07(0.83-1.39),HR 81-90 b.p.m.为 1.01(0.70-1.48),HR>90 b.p.m.为 1.35(1.12-1.62),HR>90 b.p.m.为 0.99(0.77-1.27),HR>90 b.p.m.为 0.96(0.66-1.40),HR>90 b.p.m.为 1.41(1.16-1.73),HR>90 b.p.m.为 1.01(0.76-1.36),HR>90 b.p.m.为 0.79(0.51-1.22),HR>90 b.p.m.为 1.78(1.46-2.17),HR>90 b.p.m.为 1.08(0.80-1.46),HR>90 b.p.m.为 0.73(0.46-1.17),分别在 0-2 年、2-4 年和 4-6 年的随访期间。
在 HFpEF 患者的大型未选择队列中,AF 与全因死亡率独立相关。较高的 HR 与 SR 患者死亡率增加相关。在 AF 中,较高 HR 对死亡率的影响仅在随访的前几年存在,随着长期随访中根据基线 HR 组的结果趋同,死亡率也随之趋同。